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Neurodegenerative diseases associated with abnormal protein folding and ordered aggregation require an initial trigger which
may be infectious, inherited, post-inflammatory or idiopathic. Proteolytic cleavage to generate vulnerable precursors, such as
amyloid-b peptide (Ab) production via b and c secretases in Alzheimer’s Disease (AD), is one such trigger, but the proteolytic
removal of these fragments is also aetiologically important. The levels of Ab in the central nervous system are regulated by
several catabolic proteases, including insulysin (IDE) and neprilysin (NEP). The known association of human acetylcholines-
terase (hAChE) with pathological aggregates in AD together with its ability to increase Ab fibrilization prompted us to search
for proteolytic triggers that could enhance this process. The hAChE C-terminal domain (T40, AChE575-614) is an exposed
amphiphilic a-helix involved in enzyme oligomerisation, but it also contains a conformational switch region (CSR) with high
propensity for conversion to non-native (hidden) b-strand, a property associated with amyloidogenicity. A synthetic peptide
(AChE586-599) encompassing the CSR region shares homology with Ab and forms b-sheet amyloid fibrils. We investigated the
influence of IDE and NEP proteolysis on the formation and degradation of relevant hAChE b-sheet species. By combining
reverse-phase HPLC and mass spectrometry, we established that the enzyme digestion profiles on T40 versus AChE586-599,o r
versus Ab, differed. Moreover, IDE digestion of T40 triggered the conformational switch from a-t ob-structures, resulting in
surfactant CSR species that self-assembled into amyloid fibril precursors (oligomers). Crucially, these CSR species significantly
increased Ab fibril formation both by seeding the energetically unfavorable formation of amyloid nuclei and by enhancing the
rate of amyloid elongation. Hence, these results may offer an explanation for observations that implicate hAChE in the extent
of Ab deposition in the brain. Furthermore, this process of heterologous amyloid seeding by a proteolytic fragment from
another protein may represent a previously underestimated pathological trigger, implying that the abundance of the major
amyloidogenic species (Ab in AD, for example) may not be the only important factor in neurodegeneration.
Citation: Jean L, Thomas B, Tahiri-Alaoui A, Shaw M, Vaux DJ (2007) Heterologous Amyloid Seeding: Revisiting the Role of Acetylcholinesterase in
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INTRODUCTION
Several human neurodegenerative syndromes, such as Alzhei-
mer’s, Parkinson’s, Huntington’s and Prion diseases, are thought
to possess an underlying common pathological mechanism in
which protein misfolding leads to protein aggregation and
polymerization. The polymerization process results in the
formation of amyloid fibrils with a cross-b sheet fold that deposits
and accumulates in the brain. Amyloid fibrilization is a multistep
process characterized by an energetically unfavorable formation of
nuclei (lag phase) followed by cooperative amyloid elongation. In
the case of Alzheimer’s disease (AD), the extracellular deposition of
amyloid-b-peptide (Ab) in senile plaques and intracellular de-
position of hyperphosphorylated Tau in neurofibrillary tangles are
characteristic of the pathology [1]. Ab is a 40 to 43 amino acid
peptide resulting from paired endoproteolysis of the b2amyloid
precursor protein (APP)[2,1]. Recent attention has focussed on Ab
catabolism to understand the mechanisms leading to its excessive
accumulation during AD. A number of unrelated proteases were
identified, among which insulysin (IDE) and neprilysin (NEP) are
undoubtedly involved in Ab clearance [3,4]. IDE is a thiol zinc
metalloprotease found in the brain and located mainly in cytosol
[5,6,7]. IDE cleaves a broad range of peptides and has been
proposed to be an amyloid scavenger recognizing structural b-rich
folds found in amyloid forming peptides (e.g. insulin and Ab)[4]. A
genetic linkage was found between the chromosome 10q locus
encoding IDE and onset of AD [8]. In IDE deficient mice,
cerebral levels of Ab are increased [5,7], conversely mice over-
expressing IDE and APP exhibited decreased Ab levels, reduced
plaque burden and protection from premature death [6]. NEP is
also a zinc metalloprotease found in the brain; it cleaves on the
amino side of hydrophobic residues in a variety of peptides (e.g.
substance P and enkephalin)[9]. NEP localization at the plasma
membrane makes it a candidate for degradation of extracellular
Ab [9]. NEP deficiency and over-expression studies in mice gave
comparable results to those for IDE [3,6]. Whereas IDE was found
to degrade only soluble monomeric Ab, NEP can hydrolyze both
monomeric and oligomeric Ab [10,11].
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senile plaques, other proteins such as cholinesterases have been
implicated [12,13,14,15]. The evidence is as follows; both human
acetylcholinesterase (hAChE) and butyrylcholinesterase (hBuChE)
are associated with senile plaques and both the pattern of hAChE
oligomerisation and its enzymatic activity are altered in brain
areas affected by AD [12,13,16,14,17]. BuChE inhibitors were
shown to reduce level of APP and also to improve cognitive
function in patients with moderate AD [18,19]. Whereas hAChE
activity diminishes in the cortex of AD patients, hBuChE activity
remains unchanged or increases [20,13,14] and it has been
proposed that hBuChE acts as a substitute for hAChE when
hAChE is impaired [21]. However, the role of hBuChE in normal
or AD brains remains unclear. Various studies suggest that
hAChE promotes Ab fibrilization and deposition in pathological
aggregates [22,23] but the mechanism remains unknown.
Moreover, double transgenic mice expressing human APP (hAPP)
and hAChE developed earlier disease than single transgenic hAPP
mice, accompanied by increased plaque deposition and pathology
[23]. Neurodegenerative diseases associated with abnormal pro-
tein folding and aggregation are nucleation-dependent, which
involves a slow and unfavorable nucleation phase (known as the
lag phase) during which monomers associate to form ordered
oligomeric nuclei, an elongation phase during which the nuclei
exceed a threshold size, become stable and monomers can be
added favorably to them, and finally a plateau phase in which the
monomer concentration falls below the threshold aborting further
fibril extension [24]. Because of this nucleation-dependency,
neurodegenerative diseases may require an initial trigger. This
trigger may involve different pathological pathways including the
effects of molecules acting as pathological chaperones, as well as
seeding events (defined as involvement of exogenous nuclei to
bypass the slow nucleation event), both homologous and hetero-
logous. In the case of heterologous seeding, the seed originates
independently of the molecular species that will make up the bulk
of the accumulating misfolded material. Along with hAChE, other
molecules have been shown to enhance the nucleation phase of Ab
fibrilization. For example, glycosaminoglycans and membrane
glycolipids can mediate Ab aggregation [25,26]. Thus, one may
postulate that the subtle effect of these ‘secondary’ molecules might
be heterologous seeding of Ab, which could represent one of the
trigger for more severe Ab pathology during AD.
The non-amyloidogenic and a-helical C-terminal oligomerisa-
tion domain of hAChE (T40, AChE575-614) [27,28,29] contains
a region that shares homology with Ab. Computational identifi-
cation of non-native (hidden) b-strand propensity in protein
sequences had predicted the minimal amyloidogenic fragments for
Ab and a-synuclein [30]. When applied to T40, a short and
unique predicted conformational switch region (CSR, from W585
to K599) with high propensity for conversion to non-native (hidden)
b-strand was identified (Figure 1)[31,30], with a strong propensity
for conversion to b-strand for the sequence Y594MVHWK599 and
A586EFHR590 more weakly. A peptide synthesized to include this
CSR region (AChE586-599) adopts a b-sheet conformation and self-
assembles into amyloid fibrils, a structure associated with AD
plaques [31,30]. AChE586-599 was previously identified as a region
of high hidden b-propensity by the independent computational
study that predicted the Ab and a-synuclein amyloidogenic
fragments. The mechanisms that could trigger such a conforma-
tional switch in this region are unknown but are worth seeking
since they could represent the connection between AChE and
increased Ab fibril formation during AD pathogenesis. Proteolytic
processes could liberate fibrilogenic peptides (CSR-like) from the
non-amyloidogenic and a-helical C-terminus of AChE that is
exposed in the monomer and implicated in tetramer formation
[32]. The plausibility of such a mechanism is reinforced by the
observation that hydrophilic monomers of bovine brain AChE are
not reactive with an antibody raised against the extreme C-
terminus of the T40 domain, consistent with C-terminal
truncation events [33]. Moreover, the normal reactivity of the
AChE tetrameric form with this antibody is lost after limited
proteolysis of the tetrameric species, suggesting that the T40
domain remains vulnerable to proteolysis even in assembled
tetramers [33]. Candidate proteases include IDE and NEP, which
are known to be present and active in the extracellular space of the
brain and are already clearly implicated in processing of
amyloidogenic peptides in the central nervous system.
In this study, we examined the activity of IDE and NEP on
formation of relevant b-sheet molecular species from the non-
amyloidogenic and a-helical T40 fragment of AChE and degrada-
tion of pre-assembled b-sheet oligomers. IDE cleaved both non-
amyloidogenic T40 and amyloid forming AChE586-599,w h e r e a s
NEP only cleaved the AChE586-599 substrate. Digestion of the non-
amyloidogenic and a-helical T40 by IDE triggered the formation of
b-structures that formed amyloid precursors (oligomers) and
generated surface-active CSR species (detergent-like), which seeded
Ab fibrilization by reducing the lag phase and enhancing the rate of
amyloid elongation. The heterologous seeding of Ab by IDE-
mediated amyloidogenic hAChE fragments may offer an explana-
tion for the implication of hAChE in the extent of Ab deposition in
the brain [34]. Ab heterologous seeding by proteolytic fragments
fromanotherabundantCNSproteinmayalsorepresentapreviously
undescribed pathologicaltrigger,inwhich the abundanceof Ab may
not be the only important factor in AD.
Figure 1. Secondary structure propensity of T40 as predicted by hidden b-propensity method (available at http://opal.umdnj.edu). Propensities
for helices (red squares), b-strands (blue squares) and random coil (green squares) are presented numerically using a 0-1 scale, with low values
indicating zero to low propensity and high values indicating high propensity to near certainty.
doi:10.1371/journal.pone.0000652.g001
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T40-degrading activity of IDE
We examined the effect of proteolytic processes on the non-
amyloidogenic and a-helical C-terminus of AChE (T40) that is
exposed in the monomer and implicated in tetramer formation [32].
The ability of IDE to digest T40 is depicted in the western blot
probed with a rabbit anti-T40 antiserum (KD69 antiserum)(Fi-
gure 2A). In the absence of IDE, the 5 kDa T40 migrates as
monomers and dimers. In the presence of IDE, monomeric T40 was
progressively digested with complete disappearance by 80 min
incubation, whereas a proportion of the dimeric form remained
undigested. The specific activity of IDE on T40 was demonstrated
by a dose dependent inhibition with insulin (a natural IDE substrate)
or 1,10-phenanthroline (a zinc metalloprotease inhibitor)(Figure 2B).
Complete inhibition was achieved at equimolar levels of insulin
(16 mM), which did not occur with an irrelevant protein (IgG). The
1,10-phenanthroline was prepared in methanol, which addition to
the IDE reaction did not affect degradation of T40.
To determine a full map for IDE cleavage of T40, a temporal
series of products were analyzed by mass spectrometry (MS) and
reported based upon T40 numbering (Asp
1 to Leu
40). After 2 min
incubation, four major products (a–d) were visible and corresponded
to initial cleavages between Phe
14-His
15,S e r
19-Tyr
20, and Trp
24-
Lys
25 (Figures 2C and 2D). As digest time increased, more products
appeared with peaks a and b dominating up to 15 min before peak e
became the prominent product at 30 min, coinciding with near
complete digestion of T40. The progression and regression of peaks
a–d suggests that after digestion at the primary positions, T40
fragments are serially digested to generate other peptides. A
complete digestion map of T40 by IDE after 30 min incubation is
available as supporting information (Figure S1). Peaks b to h
contained significant amounts of CSR species (Figure 2E) along with
other identified peptides. Peaks b, e and f contained species
encompassing the sequence YMVHW with high propensity for
conversion to b-sheet as major IDE cleavage products. Peak e, the
major peak at 30 min, also contained a peptide almost identical to
the previously studied AChE586-599 peptide (KAEFHRWSSYMVH
versus AEFHRWSSYMVHWK). Analysis of peaks a–h in all the
incubation times revealed that CSR species appeared very early
during digestion (from 2 min) with the number and abundance
increasing with time (Figure 2F). Species containing the high-
b propensity sequence YMVHW appeared to be the most abundant
CSR species identified during T40/IDE digest (Figure 2F, bottom
of the table). Potential precursors to CSR species were detected,
which increased and disappeared, coincident with the appearance of
smaller peptides (e.g. WKAEFHRWSSYMVHWKNQFD versus
HRWSSYMVHWK). Almost all CSR species, except
RQWKAEFHRWSSY and KAEFHRWSSYMVH, were still
present after a longer exposure to IDE (2 hours), indicating that
the CSR species are resistant to and can survive further digestion by
IDE (Figure 2F).
IDE digests monomeric and oligomeric species of
AChE586-599
IDE has been proposed to be an amyloid scavenger recognizing
structural b-rich folds found in amyloid forming peptides and has
been shown to degrade soluble monomeric Ab [4]. Since
AChE586-599 is the only hAChE peptide reported to form amyloid
fibrils, we investigated the capability of IDE to digest this peptide.
IDE degraded AChE586-599 and the initial cleavage sites of IDE on
this peptide were between Ser
8-Tyr
9, and His
12-Trp
13 (Figure 3A).
The identity of cleavage products is reported based upon
AChE586-599 synthetic peptide numbering (Ala
1 to
Lys
14)(Figure 3B). An initial IDE cleavage site was identical on
both AChE586-599 (Ser
8-Tyr
9) and T40 (Ser
19-Tyr
20), suggesting
that one of the dominant binding motifs for IDE can be found
within the AChE586-599 portion of T40. Also, a significant
proportion of generated products contained the YMVH motif of
high propensity for b-sheet conversion.
Since IDE digests only monomeric forms of Ab [35,36], we
examined the ability of IDE to degrade oligomeric AChE586-599.
AChE586-599 oligomers were recognized by monoclonal antibody
(Mab) 105A, demonstrating b-sheet conformation, and migrated
mainly as a smear of SDS-stable oligomers (4-36 kDa) (Figure 3C,
lane ‘-IDE’). In contrast to the lack of effect on Ab oligomers, IDE
degraded AChE586-599 oligomers (Figure 3C), in an insulin-
sensitive manner (data not shown). Initially (5–80 min), IDE
preferentially digested small and large oligomeric species (bottom
and top of the smear). From 160 to 480 min, the 5 and 8 kDa
species were partially degraded although persisted after 480 min
incubation, suggesting resistance to IDE. These two oligomeric
forms may correspond to trimers and pentamers according to their
observed molecular weights (AChE586-599 being 1.86 kDa).
NEP digests preferentially monomeric and
oligomeric AChE586-599
Along with IDE, NEP is an important Ab-degrading enzyme in
the brain. The levels of non-amyloidogenic monomeric and
dimeric forms of T40 remained unchanged after exposure to NEP
(Figure 4A). The control degradation of substance P confirmed the
presence of NEP activity under these assay conditions. NEP digests
both monomeric and oligomeric forms of Ab, hence it was
appropriate to test its ability to degrade monomeric and
oligomeric AChE586-599 [11]. NEP degraded AChE586-599 with
complete digestion by 4 hours (Figures 4B and 4C). Although NEP
targeted AChE586-599 more broadly than IDE, some of the
cleavages were conserved between the two enzymes (Ser
8-Tyr
9
and His
12-Trp
13, AChE586-599 numbering). Some peptides were
generated by both NEP and IDE (e.g. AEFHRWSS), however
NEP also allowed some larger peptide species to remain intact (e.g.
AEFHRWSSYMVH)(see Figures 3B and 4C).
NEP degradation of AChE586-599 oligomers was different and
less efficient than IDE with a greater range of untargeted
oligomers. Indeed, NEP only degraded the oligomer species at
10 and 16 kDa (Figure 4D, arrows), which remained intact during
240 min incubation in the absence of NEP (Figure 4D, lane ‘-
NEP’). NEP-resistant 14–15 kDa species became apparent and
might correspond to octamers according to their observed
molecular weights. As previously observed for IDE, the 5 and
8 kDa species were resistant to digestion.
To assess the potential for interrelationships between IDE and
NEP degradation, peaks e–f (see Figure 2C) from a 30 min IDE/
T40 digest were subjected to NEP digestion for 2 hours. Peaks e–f
were selected for the largest variety of CSR species among non-
CSR related peptides. NEP was capable of degrading to
completion the T40 products generated by IDE (Figure 4E).
T40/IDE digestion triggers conformational changes
Non-amyloidogenic T40 is a-helical either as a synthetic peptide
or within hAChE [27,28,29], whereas AChE586-599 adopts a b-
sheet conformation and self-assembles into amyloid fibrils [31,30].
We have shown that some of the cleavage products generated from
T40 by IDE contained CSR species encompassing motifs
predicted to have a propensity for conversion to b-sheet (e.g.
AEFHR and YMVHW). Therefore, we investigated the confor-
mation of the T40/IDE digestion products. Circular dichroism
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PLoS ONE | www.plosone.org 3 July 2007 | Issue 7 | e652Figure 2. T40-degrading activity of IDE. (A) IDE degrades non-amyloidogenic and monomeric T40. 16 mM T40 was incubated with or without 22 nM
IDE (37uC) and the reaction stopped as indicated. (B) Specificity of IDE activity. 16 mM T40 was incubated (37uC, 90 min) with no IDE, with 22 nM IDE
or with 2–16 mM insulin, 2–16 mM IgG, 1 and 10 mM 1,10-phenanthroline, or 0.3 and 3 mL methanol. For (A) and (B), digestion products were resolved
(10% Tris-Tricine SDS-PAGE), electro-blotted onto nitrocellulose and probed with KD69 (specific for the T40). Marker proteins are indicated. Arrows
indicate the positions of T40 monomers and dimers. (C) 60 mM T40 was incubated with or without 50 nM IDE (37uC) and products separated by RP-
HPLC (peaks annotated a–h). (D) Positions of IDE initial cleavages (arrows) within T40 (2 min digestion). (E) Identity of the major peptides (italics) and
of CSR species in peaks a–h, analyzed by MS. (F) The relative abundance of CSR species was determined with reference to an internal standard on the
MS spectra and is displayed as arbitrary units. ‘+’, 1 to 25 arbitrary units; ‘++’, 26 to 100; ‘+++’, 101 to 250; and ‘++++’, .250. Potential precursors of
CSR species are italicized and shown in bold. ‘*’ indicates CSR species that were not present after a 2 hour digestion of T40 by IDE.
doi:10.1371/journal.pone.0000652.g002
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various times (Figure 5A). Prior to digestion, T40 displayed an a-
helical spectrum with double minima at 209 and 222 nm. During
IDE digestion, the ellipticity at 222 nm progressively decreased,
suggesting a reduction in a-helices, accompanied by a shift of the
minimum at 209 nm toward lower wavelengths that can be
accounted by an increase of unordered structures (characterized
by a single minimum below 200 nm). The negative ellipticity in
the 210–220 nm indicated the presence of b-structures. After
digestion, the spectrum intensity was reduced in the entire far-UV
region, probably as the result of the formation of aggregates (see
below). The total digest of T40 by IDE, as shown in Figures 2C
and 2E, resulted in a mixture of peptides, not all of which
necessarily adopted a b-sheet conformation. This could explain the
complex nature of the CD spectrum observed during digestion,
which did not show a fully b2sheet conformation. Therefore, to
extract secondary structure components from the complex
spectrum, we used spectral deconvolution utilizing an algorithm
validated against the largest reported reference protein dataset
[37]. Quantification of the secondary structures revealed that up to
10 min digestion, b-structure content remained negligible (5.9%),
increasing substantially to 45.5% at 30 min, concomitant with
a decrease in a-structure (from 81% to 20.5%) and an increase in
unordered structure (from 14.9% to 37.4%)(Figure 5B). These
temporal secondary structure changes correlated with the pro-
gressive accumulation of CSR species or their precursors peaking
at 30 min (Figure 2E). When applied to three independent T40/
IDE digests of 30 min, analysis of the CD spectra by deconvolu-
tion showed large and unambiguous changes with a decrease in a-
helical content from 80.8360.38% to 14.56610.45% (p,0.008),
an increase in b-structure from 6.9060.89% to 53.70615.34%
(p,0.03), and an increase in unordered structure from
15.3760.42% to 32.9367.22%.
T40/IDE generated CSR species are surface-active
At acidic pH, AChE586-599 remains monomeric and is not surface-
active. In contrast, at neutral pH this peptide self-assembles into
amyloid fibrils and reduces the surface tension of an air-water
interface (measured by differential absorbance) in a similar
manner to Ab [38,39]. The T40/IDE products a–k (Figure 5C
inset) were analyzed for surface activity. Only peaks a, b, d, e, f and
g showed an increase of DOD at neutral pH (p,0.05), which
demonstrated their pH dependant surfactant properties
(Figure 5C). This is comparable to a reduction of surface tension
from ,72 N.m
22 at low pH to ,50 N.m
22 at neutral pH. All of
these peaks contained CSR species. Products in peaks e–f, that
contained the largest variety of CSR species including YMVHW
(with high b-propensity) as a major species, had the biggest effect
on surface tension upon neutralization. Peaks c and h were not
surface-active at neutral pH, which may be explained by the very
low levels of CSR species represented. For most of the surface-
active products (peaks a, b, e, f and g), the effect was greater than
seen with 50 mM AChE586-599. Peaks i, j and k did not contain
CSR species and did not exhibit surfactant properties upon
neutralization. Thus, some of the peptides generated by IDE
digestion of T40 share with synthetic AChE586-599 the unusual
characteristic that their surface tension effects are strongly pH
dependent, which appears to be linked with the presence of CSR
species. Moreover, these effects upon neutralization were not
solely due to the presence of hydrophobic or aromatic amino acids
in their sequences since some non surface-active peaks (e.g. peak c)
contained as many or more hydrophobic and aromatic residues as
some surface-active peaks (e.g peak a).
T40/IDE digestion promotes Ab fibrilization and
amyloid protofibril formation
Having established that T40/IDE digestion produced CSR
species, some of which possessed surfactant activity and changed
conformation from a-helical to b-structures, we examined their
ability as heterologous seeds to promote Ab fibrilization. The
quantity of Ab fibrils was determined by changes in thioflavin T
(ThT) fluorescence emission. For Ab heterologous seeding, we
used peptide seeds instead of monomers, experimental conditions
that were identical to Diamant et al and were chosen for direct
comparison with this previous study reporting the effect of hAChE
on Ab fibrilogenesis [40]. However, to preclude artifacts due to
ThT binding to peptide oligomers/seeds themselves formed
during IDE digests of T40, the values for peptide seed-ThT (no
Ab) were subtracted from all ThT assays (with Ab). Thus, while it
is possible that some experimental variation may be due to
variable seed formation, these variations were accounted for in the
statistical analysis of the experiment, which was based on three
independent T40 digest experiments with replicates within each
Figure 3. IDE degrades both monomeric and oligomeric forms of
AChE586-599. (A) Positions of IDE initial cleavages (arrows) within
AChE586-599. (B) Cleavage map after complete IDE digestion of
AChE586-599.6 3mM AChE586-599 was incubated with or without 45 nM
IDE (A) or 273 nM IDE (B)(37uC, 30 min) and RP-HPLC peaks analyzed by
MS. (C) IDE degrades AChE586-599 oligomers. AChE586-599 oligomers
(16 mM) cross-linked by photo-induced cross-linking were incubated
with or without 16.3 nM IDE (37uC). Digestion products were resolved
(16.5% Tris-Tricine SDS-PAGE), electro-blotted onto nitrocellulose and
probed with Mab 105A (specific for AChE586-599 in b-sheet conforma-
tion). Marker proteins are indicated.
doi:10.1371/journal.pone.0000652.g003
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,42 hour nucleation process (lag phase)(Figures 6A and B). The
addition of equimolar ratio of the non-amyloidogenic T40
(15 mM) to Ab did not cause any changes in the lag phase or
the apparent rate or the plateau height of Ab fibril formation. This
result confirmed that T40 did not affect fibrilogenesis even when it
was present at a 1:1 ratio with the fibrilizing substrate and
validated the use of T40 as a negative control. In contrast,
equimolar ratio of AChE586-599 seeds (15 mM) to Ab reproducibly
reduced the Ab lag phase by 11.6 fold (p,0.004), which confirmed
the use of AChE586-599 as a positive control. Even at 1.5 mM
(which represented 3.3% by mass of the total peptide), AChE586-
599 peptide reduced the Ab lag phase from 42 hours to
1360.9 hours (p,0.006)(data not shown). The total T40/IDE
digest (,10 mM starting T40) also reproducibly reduced the Ab
lag phase by 1.8 fold (p,0.006). Moreover, the total T40/IDE
digest also increased the apparent rate of fibril formation (from
48615 for Ab alone to 8276288 fluorescence units
min
21)(p,0.043) and the plateau height (from 64936930 for
Ab alone to 1233361085 fluorescence units)(p,0.003). Each
individual peak (a–h, see Figure 2C) from the T40/IDE digest also
reduced the Ab lag phase (p,0.005, p,0.05 for peak h) and some
peaks increased the plateau height (p,0.012 for peaks e–f and
p,0.0012 for peak d)(Figures 6C and D). Peaks g–h containing the
fewest CSR species were the least efficient in lag phase reduction
and plateau height increase. For the largest peptide fragments in
any of the individual digest peaks, the maximum mass ratio of seed
to soluble Ab was 5.1% and for most peaks the mass ratio was
lower. Thus, the measured kinetics show that reduced lag phase,
increased rate and elevated plateau are all significant consequences
of seeding with IDE digests of T40 (and that undigested T40 has no
significant effect on any of these parameters). The mechanisms
involved in the Ab increase of both rate of fibrilization and plateau
level after seeding with IDE digests of T40 are unknown. However,
these results are entirely consistent with the reduction in lag phase
and increase of both rate and plateau height observed when hAChE
is present during Ab fibrilogenesis [40].
The aggregation status of the total T40/IDE digest was examined
by negative staining electron microscopy, which revealed pre-
dominantly spherical structures (diameter 4–14 nm)(Figure 7). Also
observed were annular protofibrils (outer and inner diameters of 11
and 3 nm respectively), and ‘‘rods’’ (9 nm wide, 24–29 nm long)
with some appearing as ‘‘beaded chains’’ composed of spherical sub-
units. All these observations are consistent with the presence of
amyloid precursors (oligomers)[41,42,43].
DISCUSSION
A number of proteases are involved in Ab clearance in the brain,
including two metalloproteases; IDE and NEP, with IDE digesting
monomeric Ab and NEP, oligomeric Ab [10,3,4,11]. hAChE
promotes Ab fibrilization and deposition in senile plaques but the
hAChE domain involved remains uncertain [44,22]. Therefore it
is important to understand the mechanisms for the formation of
hAChE amyloid species that could increase Ab fibril formation
during AD pathogenesis.
Figure 4. NEP preferentially degrades monomeric forms of AChE586-599. (A) 60 mM of either substance P or T40 were incubated with or without
1.2 mM NEP (37uC, 4 hours) and the digestion mixture subjected to RP-HPLC. (B) Positions of NEP initial cleavages (arrows) within AChE586-599. (C)
Cleavage map after complete NEP digestion of AChE586-599.4 0mM AChE586-599 was incubated with 772 nM NEP (30 min (B) or 4 hours (C), 37uC) and
RP-HPLC peaks analyzed by MS. (D) NEP degrades AChE586-599 oligomers. AChE586-599 oligomers (14.8 mM) cross-linked by photo-induced cross-linking
were incubated with or without 285 nM NEP (37uC). Digestion products were analyzed as described in Figure 3C. Arrows indicate two digested
AChE586-599 oligomers. (E) T40/IDE products are substrates for NEP. 60 mM T40 was incubated with 50 nM IDE (37uC, 30 min) and products separated
by RP-HPLC. Peaks e–f (see Figure. 2C) were lyophilized, incubated with 772 nM NEP (37uC, 2 hours) and subjected to RP-HPLC.
doi:10.1371/journal.pone.0000652.g004
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amyloid-forming species from the exposed and non-amyloidogenic
hAChE T40 oligomerisation domain and the consequences for
heterologous seeding of Ab, a peptide thought to be the key player
during AD. IDE and NEP may not be the only or major enzymes
involved in the formation and/or clearance of hAChE species.
Nonetheless, these two enzymes, which have already been
implicated in turnover of amyloidogenic peptides, are present
and active in the relevant compartment (namely the extracellular
space of the brain) to attack an exposed part of a substrate
(hAChE) that is also present and known to associate with plaques.
hAChE T40 is exposed in the monomer and appears to remain
vulnerable to proteolysis even in assembled tetramers [33,32]. An
outcome of such proteolytic attack may be hAChE fragments that
are able to interact with Ab, promoting fibril assembly. IDE
degraded the non-amyloidogenic and a-helical T40, to generate
CSR species, but also b-sheet forms of CSR. Upon binding to
IDE, substrates undergo drastic conformational changes from a-
helical to b-strands [45]. Thereafter, cleavage occurs at the b-
strand sites [45]. Thus, the cleavage of the a-helical T40 by IDE
implies that part of T40 is able to convert to b-conformation,
which is supported by the identification within T40 of a unique
predicted CSR (W585 to K599) with high propensity for conversion
to non-native (hidden) b-strand [30]. Although IDE preference for
cleavage is after aromatic and hydrophobic residues, multiple
alignments for substrate binding can occur [46]. All IDE cleavage
sites on T40 or AChE586-599 are consistent with the preferences
previously described [46]. The T40/IDE cleavages indicate both
distinct and secondary cleavages of an initial product. Indeed,
CSR species terminating at Ser
19 may have been generated by an
initial cleavage at Ser
19–Tyr
20 of T40 followed by a second
cleavage at the N-terminus. However, species encompassing the
T40 N-terminus and terminating after Tyr
20 may have been
generated by distinct cleavage events. Both IDE and NEP
appeared to digest primarily from the C-terminus of either T40
(IDE) or AChE586-599 peptide (IDE and NEP). Although NEP
hydrolyses Ab at specific sites, the enzyme digested AChE586-599 at
almost every peptide bond in a non-specific manner. In contrast to
Ab, IDE acted on both monomeric and oligomeric AChE586-599
species (compared with only monomeric species for Ab), whereas
NEP acted mainly on monomeric species (compared with
monomeric and oligomeric species for Ab)[10,11]. The fact that
IDE was able to digest some oligomeric species of AChE586-599 is
not inconceivable since the enzyme was shown to degrade
substrate above 50 amino acids [47,45]. However, such big
substrates are less likely to be entrapped by IDE catalytic cleft and
their degradation would be much slower. This could explain the
‘lack’ of efficiency of IDE towards some AChE586-599 oligomers
and the relatively slow digestion process when compared to T40 or
monomeric AChE586-599. Very few cleavage sites on Ab and
hAChE peptides are in common and are as follows; His
12-Trp
13
and Trp
13-Lys
14 for IDE, and Ser
8-Tyr
9 for NEP (AChE586-599
peptide numbering)(Figure S2 supporting information).
Significant differences were observed between the degradation
capability of IDE and NEP. In contrast to NEP, IDE digested T40
and a bigger variety of AChE586-599 oligomers. However in
conditions that allowed complete degradation of the monomeric
AChE586-599 species, small AChE586-599 oligomeric species were
slowly digested by IDE and untouched by NEP and some
AChE586-599 oligomers were more resistant to degradation by both
IDE and NEP. IDE was also more efficient (1 IDE:1200 peptides
versus 1 NEP:52 peptides). One could postulate that IDE
independently mediates the formation of CSR species and the
clearance of soluble and some insoluble aggregates, whereas NEP
could be involved in the clearance of the newly formed soluble
CSR species. Indeed, we have demonstrated that CSR species
generated from the T40 by IDE are a substrate for NEP.
Therefore, if modification of hAChE by IDE occurs in vivo, both
IDE and NEP deficiencies could alter the brain levels of CSR
species and increase the risk of oligomerisation and fibril
deposition. Indeed, reduced levels of these enzymes would still
allow the formation of pathological species (albeit at a reduced
rate) that could assemble into insoluble oligomers and fibrils,
Figure 5. Conformation and surfactant properties of CSR species
generated from T40 by IDE. (A) and (B) T40/IDE digestion triggers
a switch to b-structure. T40 CD spectra (250 to 190 nm) before and after
addition of IDE (A) and percentage of secondary structures (B). (C) CSR
species are surface-active. T40/IDE digest (30 min) was subjected to RP-
HPLC. Peaks (a–k, as annotated in the inset) were lyophilized, re-
suspended in 200 mM sodium acetate pH 3 and surface tension
measured before and after neutralization (1M NaH2PO4, pH7.2). Surface
tension calculations were as described in Methods. ‘*’ p,0.05, and ‘**’
p,0.007.
doi:10.1371/journal.pone.0000652.g005
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these enzymes are abundant) would be severely compromised. The
small oligomer species resistant to both IDE and NEP could be
initiating-agents in early pathological reactions. IDE activity was
decreased in soluble fractions from the brain of AD patients
compared to normal control brains [48], which suggests that
a decrease in enzyme activity could be responsible for the
increased accumulation of pathologic amyloid peptides during
AD. It was also reported that in AD brain, IDE is less effective
because it is oxidized [49]. NEP mRNA levels were reduced in
amyloid affected areas of sporadic AD brain, which could be the
cause of Ab deposition [50].
IDE cleavage of the non-amyloidogenic T40 triggered a con-
formational change from a- to predominantly b-structure,
a transition that was also observed for other amyloid proteins
(e.g. insulin and prion protein)[51,52]. Although native Ab is
unordered, a-helix formation is a key step for fibril assembly [53].
Several amyloid proteins, a-helical in the native state, contain
stretches of a-helix in places that are predicted to form b-strand.
These helices could form b-strands by unfolding into intermediates
less likely to refold into a helical conformation [54]. Moreover,
helical aggregates may convert short-range to long-range interac-
tions triggering a b-transition [55]. Computational identification of
non-native (hidden) b-strand propensity in protein sequences has
predicted the minimal amyloidogenic fragments for Ab and a-
synuclein [30]. When applied to T40, two regions with a strong
propensity for conversion to b-strand were recognized,
YMVHWK the strongest and AEFHR more weakly (Figure 1),
which is consistent with the fact that fragments (peaks e–f)
containing these regions are the most surface-active. In the larger
context of protein aggregation, our results support the importance
of gatekeeper residues in preventing the conformational switch
that leads to the formation of b-sheets and amyloid fibrils [56].
Evolutionary pressure may have sequestered CSR within T40 to
maintain conformational integrity and to protect against delete-
rious misfolding.
Several intermediates of amyloid fibril formation have been
identified with the first stage being spherical structural units that
could associate to form beaded protofibrils from which fibrils
nucleate and elongate [41,43,1]. Spherical oligomers from Ab and
a-synuclein specifically increase membrane conductivity [57]. Ab
(Arctic variant) and a-synuclein also form annular spheres
resembling bacterial pore-forming toxins [42,43]. The formation
of pores in membranes may be one mechanism for the cytotoxicity
seen in neurodegenerative diseases. In the case of Ab, there is still
controversy regarding the identity of the pathological species
(monomers, small oligomers, large oligomers or fibrils) [58,59].
However, several recent studies suggested that cognitive dysfunc-
tion correlates better with cortical levels of soluble oligomeric
rather than insoluble (fibrilar) Ab [60,61,62]. In our case, the
surfactant and amyloidogenic CSR species generated by IDE
might lead to an increased concentration of potentially toxic
oligomeric forms, whether these are homo-oligomers of b-strand
CSR species or hetero-oligomers also containing Ab. The
existence of such heterologous interactions is established in this
study by the demonstration that the lag phase of Ab assembly is
reduced by the CSR species. However, the molecular details of the
heterologous interaction remain to be characterized.
IDE catalysis generated CSR species that are highly dependent
on pH for their surface-tension activity, which appeared to be
solely the consequence of the presence of some CSR species and
could not be explained by only the presence of hydrophobic or
aromatic residues within the peptide sequences. In the case of Ab,
the surfactant properties were proposed to be detergent-like and
Figure 6. T40/IDE digestion products promote Ab fibrilization. 15 mMA b was incubated with 165 mM ThT, with or without 15 mM T40, 15 mM
AChE586-599 seeds, RP-HPLC isolated T40/IDE total digest or individual peaks (a–h, see Figure. 1C)(,10 mM starting T40). Changes in ThT fluorescence
were monitored (A and C) with the lag phase of Ab fibrilization depicted (B and D). ‘*’ p,0.006 (B) and p,0.05 (D). Control experiments showed that
there was no carry over of IDE activity in the T40/IDE digest under the sample preparation conditions (RP-HPLC and lyophilizations).
doi:10.1371/journal.pone.0000652.g006
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in lysosomes, release of lysosome contents and cell death [38].
AChE586-599 and CSR species from the T40/IDE digest were also
surface-active. Thus, one could propose that both AChE586-599
and CSR species are detergent-like and could potentially
permeabilize membranes. For AChE586-599, surfactant activity
was directly linked to the threshold concentration for fibril
formation [39], suggesting that surface-active T40 generated
CSR species might also assemble into higher oligomeric species.
Indeed, like other amyloid proteins, the T40/IDE digest formed
amyloid protofibrils (spheres, annular spheres and ‘‘beaded rods’’),
which could contribute to neuronal toxicity in AD. Thus unlike
the islet amyloid polypeptide for example, of which nested
amyloidogenic peptides that formed fibrils were originated from
an already amyloidogenic parent peptide [63], IDE digestion
converted T40 (a-helical and non-amyloidogenic) into internal
fragments that form b-sheet and are amyloidogenic.
hAChE was reported to increase Ab fibrilization, an effect that
was not mediated by isolated T40 [40]. Under the same
experimental conditions, we confirmed that the non-amyloido-
genic T40 does not promote Ab fibril formation. In contrast,
products generated from a T40/IDE digest and AChE586-599
seeded Ab, an effect measured as a reduction in lag phase in a fibril
formation assay (by 2 and 11 fold respectively) and the T40/IDE
digest also increased the rate of Ab fibril formation (by 17 fold).
This result underlines the importance of the T40 CSR, which is
included within the T40/IDE products and AChE586-599, and
provides an insight into the identity of an AChE domain that may
cooperate with Ab during AD pathogenesis.
In conclusion, we have clearly demonstrated that IDE-
dependent cleavage of the non-amyloidogenic hAChE oligomer-
isation domain leads to a conformational switch to b-structure and
liberates surface-active peptides that assemble into amyloid
protofibrils and seed the aggregation of hetero-oligomers com-
prised of Ab and CSR species. Therefore, IDE-mediated
formation of amyloidogenic hAChE fragments may provide useful
targets for the identification of fibrilogenic hAChE-derived species
in the brain, which has so far been impossible due to the lack of
information about relevant hAChE species. While the CSR
peptides themselves may offer a potential target in the struggle to
prevent abnormal protein aggregation in the brain, our results
suggest that simply increasing IDE and NEP activity may not be as
beneficial as anticipated. Furthermore, the role of the non-
amyloidogenic AChE T40 domain in heterologous seeding
interactions may have to be re-appraised in light of the proteolytic
events reported here. To our knowledge, this study represents the
first evidence of heterologous amyloid seeding by a proteolytic
fragment from another protein. Such seeding could represent
a novel initial trigger for not only AD but also other
neurodegenerative diseases sharing common characteristics, in
which the abundance of the major amyloidogenic specie may not
be the only important factor.
MATERIALS AND METHODS
Synthetic peptides, inhibitors and antibodies
T40 and AChE586-599 were prepared as described [28]. Insulin, 1,10-
phenanthroline and substance P were from Sigma-Aldrich (UK).
Ab1-40 (EZBiolab,USA) was dissolved in DMSO at 1.6 mM.Specific
rabbit anti-T40 antiserum (KD69) was raised with T40 conjugated to
keyhole limpet hemocyanin using standard procedures.
Preparation of AChE586-599 oligomers
AChE586-599 oligomers were covalently cross-linked by photo-
activation using the photo-induced cross-linking of unlabelled
proteins (PICUP)[64]. In the dark, 0.3 nmoles of AChE586-599 and
94 mM tris-bipyridyl ruthenium salts in 500 mM NaH2PO4 buffer
pH 7.2 were incubated with 1.9 mM ammonium persulfate
(30 sec). The reaction mixture was exposed to light (50 W
mercury arc lamp filtered via 5 cm H2O and a 400 nm UV
blocking filter) for 1 sec, and quenched in the dark with 89 mM
DTT before ultrafiltration (10 kDa filter) and dilution with H2O.
IDE and NEP activity assays
IDE and NEP (Merck, UK) digestions were at 37uC in 100 mM
KHPO4/KH2PO4 buffer pH 7.5 (buffer A) or 100 mM Tris-HCl
pH 7.4, 1% Triton X-100 (buffer B) respectively. 16 mMT 4 0w a s
incubated with 22 nM IDE or 309 nM NEP, and 16 or 14.8 mM
AChE586-599 oligomers with 16.3 nM IDE or 285 nM NEP.
Reactions were stopped by boiling in a Laemmli’s dissociation buffer
with 100 mM DTT and subjected to SDS-PAGE (10% Tris-Tricine
for T40 and 16.5% Tris-Tricine for AChE586-599 oligomers).
To identify degradation products, 60 mM T40 was incubated
with 50 nM IDE; 63 mM AChE586-599 with 45 nM or 273 nM
Figure 7. T40/IDE digestion products form amyloid protofibrils.
Electron micrographs of negatively stained T40/IDE total digest
showing spherical (A) annular (B, I–II) and beaded (C, III) protofibrils.
The bar represents 10 nm.
doi:10.1371/journal.pone.0000652.g007
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by reverse phase-HPLC (RP-HPLC). Peaks were collected and
identities determined on a Q-TOF Micro mass spectrometer
(Micromass, UK) with MassLynx 4.0 and MaxEnt 3 software.
Lyophilized HPLC separated T40/IDE products were used for
surface tension and seeding experiments.
60 mM substance P or T40 were incubated with or without
1.2 mM NEP (4 hours), stopped (0.5% trifluoroacetic acid) and
subjected to RP-HPLC.
RP-HPLC
Reaction products were resolved by RP-HPLC with a Sephasil C4
column (5 mm, 4.66250 mm; Amersham Biosciences, UK) using
a 5–95% linear gradient of acetonitrile in 0.1% trifluoroacetic acid
over 25 min (flow rate 1 ml/min). The eluent was monitored by
UV absorption at 280 nm.
Western-blot
Nitrocellulose membranes were blocked with 5% (w/v) non-fat
milk in PBS and incubated with KD69 anti-T40 antiserum or with
the Mab 105A recognizing AChE586-599 in b-sheet conformation
[28], followed by anti-rabbit or anti-mouse IgG conjugated to
horseradish peroxidase (HRP). Products were visualized by
enhanced chemiluminescence.
Surface tension measurement
Analyses were performed in a 96-well plate format, as described
[39]. Briefly, HPLC purified/lyophilized products were re-
suspended in 80 mL 200 mM sodium acetate pH 3 and surface
tension measured at 450 nm (BMG Polarstar plate reader) before
and after neutralization (20 mL 1M NaH2PO4, pH7.2). DO-
D=(ODoffset position –ODcentral position)neutral pH–(ODoffset position –
ODcentral position)acidic pH. At least three independent assays were
performed and analyzed with the two-sample t-test.
Circular dichroism
CD-spectra were recorded from 250 to 190 nm at 20uCi naq u a r t z
cuvette (1 mm path length) using a Jasco J-720 spectropolarimeter.
The spectrum of 100 mM T40 in buffer A was recorded before
additionof83nMIDE.Thereactionmixturewasincubatedat37uC
for various times, cooled briefly on ice before spectrum recording.
The mean spectraofmultiplescans(scan speed of 50 nm min
21 and
response time 4 sec) were deconvoluted with Selcon3 [37].
Seeding experiments
HPLC separated/lyophilized T40/IDE products were treated as for
surface tension measurement, and then re-lyophilized, re-suspended
in buffer B and incubated for 2 hours at 37uC. Control experiments
showed that there was no carry over of IDE activity under the
sample preparation conditions (RP-HPLC and lyophilizations). The
quantity of products was normalized to the height of the RP-HPLC
peaks. AChE586-599 seeds were prepared by incubating 200 mM
AChE586-599 in PBS for 3 hours under continuous agitation.
Individual T40/IDE products or the total digest (,10 mM starting
T40), 15 mMA C h E 586-599 seeds and 15 mM T40 were dispensed in
a 96-well plate (black wall, clear bottom; Greiner, UK) with 15 mM
Ab and 165 mM ThT in PBS. 15 mMA b in buffer B was used as
a control for fibrilization. ThT fluorescence (excitation 450 nm,
emission 480 nm) was measured at 37uC every 20 min, with 5 min
shaking after every measurement, on a BMG Polarstar plate reader.
The values of peptide-ThT were subtracted from the values of
peptide-Ab-ThT. At least three independent assays were performed
and analyzed with the two-sample t-test.
Electron microscopy
T40/IDE digest (30 min), as prepared for the seeding experiment,
was adsorbed onto Formvar-coated 400 mesh copper grids, air
dried, washed with distilled water, negatively stained with 2%
aqueous uranyl acetate and viewed with a Zeiss Omega 912
microscope.
SUPPORTING INFORMATION
Figure S1 Cleavage map after complete digestion of T40 by
IDE. 60 mM T40 was incubated with 50 nM IDE for 30 min at
37uC. The products were loaded onto a C4 reverse-phase HPLC
column and separated using a 5–95% linear gradient of
acetonitrile. HPLC product peaks were collected manually and
their identities were determined by mass spectrometry. The full-
length T40 sequence is shown at the top of the complete map.
CSR species are shown in white letters on a black background.
Found at: doi:10.1371/journal.pone.0000652.s001 (0.81 MB
DOC)
Figure S2 Positions of IDE and NEP major cleavage sites within
T40, AChE586-599 and Ab
1-42 sequences. (A) Positions of IDE
major cleavage sites within T40, AChE586-599 and Ab
1-42
sequences. The cleavage sites of IDE within Ab
1-42 sequences
were adapted from Mukherjee et al ((2000) J Neurosci 20: 8745-9).
(B) Positions of NEP major cleavage sites within AChE586-599
and Ab
1-42 sequences. The cleavage sites of NEP within Ab
1-42
sequences were adapted from Carson et al ((2002) J Neurochem
81: 1-8). Gaps indicated by ‘-’ are introduced to maximise
homology between T40 and Ab
1-42 sequences. Major cleavage
sites are noted with arrows. Dashed arrows underneath the
sequences represent cleavage sites occurring at a common peptide
bond within hAChE peptides and Ab
1-42 sequences.
Found at: doi:10.1371/journal.pone.0000652.s002 (0.11 MB
DOC)
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